|
1ANW
THE EFFECT OF METAL BINDING ON THE STRUCTURE OF ANNEXIN V AND IMPLICATIONS FOR MEMBRANE BINDING
提交 1993-10-26
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–319(319 aa)
|
未记录
|
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.40 Å
|
|
1ANW
THE EFFECT OF METAL BINDING ON THE STRUCTURE OF ANNEXIN V AND IMPLICATIONS FOR MEMBRANE BINDING
提交 1993-10-26
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
1–319(319 aa)
|
未记录
|
CA CALCIUM ION × 2
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.40 Å
|
|
1ANX
THE CRYSTAL STRUCTURE OF A NEW HIGH-CALCIUM FORM OF ANNEXIN V
提交 1993-10-26
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–319(319 aa)
|
未记录
|
CA CALCIUM ION × 4
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 1.90 Å
|
|
1ANX
THE CRYSTAL STRUCTURE OF A NEW HIGH-CALCIUM FORM OF ANNEXIN V
提交 1993-10-26
|
配体/离子不同
结构质量不同
|
Assembly 2
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
1–319(319 aa)
|
未记录
|
CA CALCIUM ION × 4
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 1.90 Å
|
|
1ANX
THE CRYSTAL STRUCTURE OF A NEW HIGH-CALCIUM FORM OF ANNEXIN V
提交 1993-10-26
|
配体/离子不同
结构质量不同
|
Assembly 3
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 C
1–319(319 aa)
|
未记录
|
CA CALCIUM ION × 4
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 1.90 Å
|
|
1AVR
CRYSTAL AND MOLECULAR STRUCTURE OF HUMAN ANNEXIN V AFTER REFINEMENT. IMPLICATIONS FOR STRUCTURE, MEMBRANE BINDING AND ION CHANNEL FORMATION OF THE ANNEXIN FAMILY OF PROTEINS
提交 1991-10-17
|
配体/离子不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–319(319 aa)
|
未记录
|
CA CALCIUM ION × 5
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.30 Å
|
|
1HAK
CRYSTAL STRUCTURE OF RECOMBINANT HUMAN PLACENTAL ANNEXIN V COMPLEXED WITH K-201 AS A CALCIUM CHANNEL ACTIVITY INHIBITOR
提交 1997-12-10
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
1–319(319 aa)
片段:ANNEXIN FOLD
链 B
1–319(319 aa)
片段:ANNEXIN FOLD
|
未记录
|
K21 4-[3-{1-(4-BENZYL)PIPERODINYL}PROPIONYL]-7-METHOXY-2,3,4,5-TERTRAHYDRO-1,4-BENZOTHIAZEPINE × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
pH 7.5;pH 7.5
|
分辨率 3.00 Å
R-free 0.331
|
|
1HVD
STRUCTURAL AND ELECTROPHYSIOLOGICAL ANALYSIS OF ANNEXIN V MUTANTS. MUTAGENESIS OF HUMAN ANNEXIN V, AN IN VITRO VOLTAGE-GATED CALCIUM CHANNEL, PROVIDES INFORMATION ABOUT THE STRUCTURAL FEATURES OF THE ION PATHWAY, THE VOLTAGE SENSOR AND THE ION SELECTIVITY FILTER
提交 1994-06-29
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–319(319 aa)
|
未记录
|
CA CALCIUM ION × 4
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.00 Å
|
|
1HVE
STRUCTURAL AND ELECTROPHYSIOLOGICAL ANALYSIS OF ANNEXIN V MUTANTS. MUTAGENESIS OF HUMAN ANNEXIN V, AN IN VITRO VOLTAGE-GATED CALCIUM CHANNEL, PROVIDES INFORMATION ABOUT THE STRUCTURAL FEATURES OF THE ION PATHWAY, THE VOLTAGE SENSOR AND THE ION SELECTIVITY FILTER
提交 1994-06-29
|
配体/离子不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–319(319 aa)
|
未记录
|
CA CALCIUM ION × 5
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.30 Å
|
|
1HVF
STRUCTURAL AND ELECTROPHYSIOLOGICAL ANALYSIS OF ANNEXIN V MUTANTS. MUTAGENESIS OF HUMAN ANNEXIN V, AN IN VITRO VOLTAGE-GATED CALCIUM CHANNEL, PROVIDES INFORMATION ABOUT THE STRUCTURAL FEATURES OF THE ION PATHWAY, THE VOLTAGE SENSOR AND THE ION SELECTIVITY FILTER
提交 1994-06-29
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–319(319 aa)
|
未记录
|
CA CALCIUM ION × 5
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 2.00 Å
|
|
1HVG
STRUCTURAL AND ELECTROPHYSIOLOGICAL ANALYSIS OF ANNEXIN V MUTANTS. MUTAGENESIS OF HUMAN ANNEXIN V, AN IN VITRO VOLTAGE-GATED CALCIUM CHANNEL, PROVIDES INFORMATION ABOUT THE STRUCTURAL FEATURES OF THE ION PATHWAY, THE VOLTAGE SENSOR AND THE ION SELECTIVITY FILTER
提交 1994-06-29
|
配体/离子不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–319(319 aa)
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
mmCIF 未提供已读取条件
|
分辨率 3.00 Å
|
|
1SAV
HUMAN ANNEXIN V WITH PROLINE SUBSTITUTION BY THIOPROLINE
提交 1997-11-24
|
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–319(319 aa)
|
突变:P13, P87, P119, P163, AND P248 SUBSTITUTED WITH THIOPROLINE (PRS)
非标准单体:是(mmCIF未提供具体位点)
|
CA CALCIUM ION × 5
|
X-RAY DIFFRACTION
X-ray结晶条件
pH 8.5;PROTEIN WAS CRYSTALLIZED FROM 2.1 M AMMONIUM SULFATE, 0.1 M TRIS-HCL, PH 8.5
|
分辨率 2.50 Å
R-free 0.259
|
|
2XO2
Human Annexin V with incorporated Methionine analogue Azidohomoalanine
提交 2010-08-09
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–320(320 aa)
|
突变:YES
非标准单体:是(mmCIF未提供具体位点)
|
CA CALCIUM ION × 2
NA SODIUM ION × 1
SO4 SULFATE ION × 2
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
pH 8.5;2.0 M AMMONIUM SULFATE, 20 MM CALCIUM CHLORIDE, 0.1 M TRIS/HCL, PH 8.5
|
分辨率 2.80 Å
R-free 0.296
|
|
2XO3
Human Annexin V with incorporated Methionine analogue Homopropargylglycine
提交 2010-08-09
|
构建体不同
突变/修饰不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–320(320 aa)
|
非标准单体:是(mmCIF未提供具体位点)
|
CA CALCIUM ION × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
pH 8.5;2.0 M AMMONIUM SULFATE, 20 MM CALCIUM CHLORIDE, 0.1 M TRIS/HCL, PH 8.5
|
分辨率 2.30 Å
R-free 0.291
|
|
6K22
Crystal structure of Ca-bound human Annexin A5 in low salt condition
提交 2019-05-13
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
2–320(319 aa)
|
未记录
|
CA CALCIUM ION × 3
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;287 K;0.2 M Potassium Citrate Tribasic pH 8.3
0.1 M HEPES pH 7.5
17% PEG3350
50uM CaCl2
2mM TCEP
|
分辨率 2.75 Å
R-free 0.306
|
|
6K25
Crystal structure of Ca-unbound human Annexin A5 in low salt condition
提交 2019-05-13
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
2–320(319 aa)
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;288 K;0.2 M Sodium phosphate dibasic dehydrate
20% w/v Polyethylene glycol 3,350
2 mM TCEP
|
分辨率 2.40 Å
R-free 0.292
|
|
8GYC
Annexin A5 protein dimer mutant
提交 2022-09-22
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白同源多聚体
同源多聚体;蛋白 × 2
PDB 声明:dimeric
|
链 A
2–320(319 aa)
链 B
2–320(319 aa)
|
未记录
|
CA CALCIUM ION × 7
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;289.15 K;PEG 3350, sodium chloride, 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid
|
分辨率 1.80 Å
R-free 0.288
|
|
8H0J
Annexin A5 mutant
提交 2022-09-29
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
2–320(319 aa)
|
未记录
|
CA CALCIUM ION × 5
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;289.15 K;PEG 3350, sodium chloride, 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid
|
分辨率 2.23 Å
R-free 0.246
|
|
8H9Z
Annexin A5 protein mutant
提交 2022-10-26
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
2–320(319 aa)
|
未记录
|
CA CALCIUM ION × 8
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;289.15 K;PEG 3350, sodium chloride, 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid
|
分辨率 1.42 Å
R-free 0.265
|